ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 166 filers reported holding ANTARES PHARMA INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $293,000 | -45.8% | 71,367 | -52.9% | 0.00% | 0.0% |
| Q4 2021 | $541,000 | -33.9% | 151,606 | -32.6% | 0.00% | -50.0% |
| Q3 2021 | $819,000 | +47.8% | 225,049 | +77.1% | 0.00% | 0.0% |
| Q2 2021 | $554,000 | +808.2% | 127,060 | +728.3% | 0.00% | – |
| Q4 2020 | $61,000 | -11.6% | 15,339 | -40.3% | 0.00% | -100.0% |
| Q3 2020 | $69,000 | -86.2% | 25,700 | -85.8% | 0.00% | -87.5% |
| Q2 2020 | $499,000 | +43.4% | 181,604 | +23.1% | 0.01% | -11.1% |
| Q1 2020 | $348,000 | -73.1% | 147,536 | -46.3% | 0.01% | +12.5% |
| Q4 2019 | $1,292,000 | +1118.9% | 274,853 | +769.5% | 0.01% | +700.0% |
| Q3 2019 | $106,000 | +63.1% | 31,609 | -48.9% | 0.00% | -75.0% |
| Q2 2016 | $65,000 | -5.8% | 61,900 | +7.8% | 0.00% | -50.0% |
| Q4 2015 | $69,000 | – | 57,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
| Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
| Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
| Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
| PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
| Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
| ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |